US Patent 10406216 In situ antigen-generating cancer vaccine

Patent 10406216 was granted and assigned to President and Fellows of Harvard College on September, 2019 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

‌

President and Fellows of Harvard College

Current Assignee

‌

President and Fellows of Harvard College

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

10406216

Date of Patent

September 10, 2019

Patent Application Number

15345131

Date Filed

November 7, 2016

Patent Citations Received

‌

US Patent 11998593 Combination vaccine devices and methods of killing cancer cells

‌

US Patent 11555177 Antigen-presenting cell-mimetic scaffolds and methods for making and using the same

Patent Primary Examiner

‌

Sean E Aeder

Patent abstract

The invention provides compositions and methods for utilizing scaffolds in cancer vaccines.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10406216 In situ antigen-generating cancer vaccine

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API